HBM Alpha Therapeutics

Carthage, New York, United States

http://www.hbmalphatx.com

Company profile

HBM Alpha Therapeutics company profile

HBM Alpha Therapeutics is a biotechnology company that is currently developing antibody therapeutics for the rare genetic diseases congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS) (PCOS). Its therapeutics could also be used to treat other endocrinological diseases associated with hypothalamic-pituitary-adrenal (HPA) axis dysregulation and dysfunction.

Business identity

Website: http://www.hbmalphatx.com
Contact email: [email protected].
Operating status: Active
Company type: For Profit
Employee range: 00011-00050 employees
Founded: 2019-01-01

Headquarters

Headquarters: Carthage, New York, United States
Country code: US
Continent: North America

Capital profile

Funding and company signals

Funding stage: Seed
Funding rounds: 1
Last funding: Seed / 2023-01-25
Last equity funding: Seed
Investors: 1
Lead investors: 1
Articles: 10

Categories and groups

Biotechnology Medical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Harbour Biomed

Investors

Harbour Biomed

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.